Adjuvant therapy for endometrial cancer

Maria C. DeLeon, Natraj R. Ammakkanavar, Daniela Matei

Research output: Contribution to journalReview article

17 Scopus citations


Endometrial cancer is a common gynecologic malignancy typically diagnosed at early stage and cured with surgery alone. Adjuvant therapy is tailored according to the risk of recurrence, estimated based on the International Federation of Gynecology and Obstetrics (FIGO) stage and other histological factors. The objective of this manuscript is to review the evidence guiding adjuvant therapy for early stage and locally advanced uterine cancer. For patients with early stage disease, minimizing toxicity, while preserving outstanding cure rates remains the major goal. For patients with locally advanced endometrial cancer optimal combined regimens are being defined. Risk stratification based on molecular traits is under development and may aid refine the current risk prediction model and permit personalized approaches for women with endometrial cancer.

Original languageEnglish (US)
Pages (from-to)136-147
Number of pages12
JournalJournal of Gynecologic Oncology
Issue number2
StatePublished - Jan 1 2014


  • Adjuvant therapy
  • Early stage
  • Endometrial cancer
  • Locally advanced
  • Risk stratification

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Fingerprint Dive into the research topics of 'Adjuvant therapy for endometrial cancer'. Together they form a unique fingerprint.

  • Cite this